Avidity Biosciences, Inc. Quarterly Marketable Securities, Current in USD from Q4 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Avidity Biosciences, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2022.
Avidity Biosciences, Inc. Marketable Securities, Current for the quarter ending September 30, 2022 was $262M, a 8582% increase year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$262M	+$259M	+8582%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$273M	+$270M	+8899%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$258M	+$251M	+3782%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$85.1M	+$78.4M	+1174%	Dec 31, 2021	10-Q	2022-11-08
Q3 2021	$3.02M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$3.04M			Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$6.64M			Mar 31, 2021	10-Q	2021-05-12
Q4 2020	$6.68M			Dec 31, 2020	10-K	2022-03-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.